2022
Texas CARES: COVID-19 antibodies can last 7 months in children
March 18, 2022
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston School of Public Health. Read the article here.
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey
May 6, 2022
The Texas CARES team examined how long antibodies from a COVID-19 infection lasted among Texas CARES participants. The findings were published in The Journal of Infectious Diseases. Read the article here.
Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents
May 27, 2022
Texas CARES researchers examined how long antibodies from a COVID-19 infection lasted in participants ages 5-19 years old. The findings were published in Pediatrics. Read the article here.
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents
August 1, 2022
The Texas CARES team examined the presence of persistent COVID symptoms — or long COVID — in children by COVID-19 antibody status between October 2020 and May 2022. The article was published in The Pediatric Infectious Disease Journal. Read the article here.
Texas CARES: Kids with mild COVID-19 can still have persistent COVID-19 symptoms
August 8, 2022
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection. Read the article here.
Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region
September 9, 2022
Texas CARES researchers determined a way to estimate antibodies to COVID-19 infections and COVID-19 vaccinations in people living in a large region. The findings were published in PLOS ONE. Read the article here.
UTHealth researchers create better way to estimate COVID-19 infections in communities
September 12, 2022
Public health and safety strategies are only as effective as the information that guides them. Researchers and scientists at UTHealth Houston developed a more accurate way to estimate the percentage of community members with some level of protection from antibodies developed in response to COVID-19 infection or vaccination. These findings could help shape public pandemic preparedness both now and in the future. Read the article here.